PVLA

Palvella Therapeutics, Inc.$128.11-0.53 (-0.41%)

Prev Close$128.64·MCap$1.50B·P/E—·Vol253.6K·Yield—

▲

Buys (12M)

$850.0K

▼

Sells (12M)

$2.94M

◆

Net Activity

Net Seller

$2.09M

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Palvella Therapeutics, Inc. (PVLA) has been dominated by selling, with 3 insider purchases totaling $850.0K and 7 insider sales totaling $2.94M. The most recent insider transaction was by Goin Kathleen (officer: Chief Operating Officer), who sold $547.4K worth of shares on Apr 17, 2026. Palvella Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.50B.

PVLA Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Apr 17, 2026	Goin Kathleen	officer: Chief Operating Officer	Sell	4,302	$127.24	$547.4K	2,800-61%
Apr 1, 2026	JENKINS GEORGE M	director	Buy	445	$112.30	$50.0K	187,616
Mar 20, 2026	Goin Kathleen	officer: Chief Operating Officer	Sell	4,302	$117.99	$507.6K	2,034-68%
Mar 2, 2026	HERON ELAINE J	director	Buy	2,400	$125.00	$300.0K	47,812
Mar 2, 2026	JENKINS GEORGE M	director	Buy	4,000	$125.00	$500.0K	187,171
Feb 20, 2026	Goin Kathleen	officer: Chief Operating Officer	Sell	4,302	$79.40	$341.6K	1,276-77%
Feb 18, 2026	Goin Kathleen	Chief Operating Officer	Sell	4,302	$79.40	$341.6K	0
Jan 23, 2026	Goin Kathleen	officer: Chief Operating Officer	Sell	4,302	$97.63	$420.0K	3,749-53%
Dec 19, 2025	Goin Kathleen	Chief Operating Officer	Sell	4,302	$96.47	$415.0K	0Exit
Nov 21, 2025	Goin Kathleen	Chief Operating Officer	Sell	4,302	$86.23	$371.0K	2,802-61%
Apr 10, 2025	JENKINS GEORGE M	Director	Buy	4,990	$20.20	$100.8K	183,171
Dec 19, 2024	JENKINS GEORGE M	Director	Buy	4,000	$12.93	$51.7K	180,671
Aug 12, 2024	ADAR1 Capital Management, LLC	10% Owner	Buy	6,000	$15.39	$92.3K	129,574
May 30, 2023	KIRITSY CHRISTOPHER P		Buy	10,000	$0.85	$8.5K	20,000+100%
May 16, 2022	Demuth Tim	Chief Medical Officer	Buy	6,000	$1.71	$10.3K	6,000
Sep 1, 2021	Olwill Shane	Chief Development Officer	Sell	38,400	$5.11	$196.4K	33,838-53%

PVLA Insider Buying Activity

The following table shows recent insider purchases of Palvella Therapeutics, Inc. (PVLA) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Apr 1, 2026	JENKINS GEORGE M	director	Buy	445	$112.30	$50.0K	187,616
Mar 2, 2026	HERON ELAINE J	director	Buy	2,400	$125.00	$300.0K	47,812
Mar 2, 2026	JENKINS GEORGE M	director	Buy	4,000	$125.00	$500.0K	187,171
Apr 10, 2025	JENKINS GEORGE M	Director	Buy	4,990	$20.20	$100.8K	183,171
Dec 19, 2024	JENKINS GEORGE M	Director	Buy	4,000	$12.93	$51.7K	180,671
Aug 12, 2024	ADAR1 Capital Management, LLC	10% Owner	Buy	6,000	$15.39	$92.3K	129,574
May 30, 2023	KIRITSY CHRISTOPHER P		Buy	10,000	$0.85	$8.5K	20,000+100%
May 16, 2022	Demuth Tim	Chief Medical Officer	Buy	6,000	$1.71	$10.3K	6,000

PVLA Insider Selling Activity

The following table shows recent insider sales of Palvella Therapeutics, Inc. (PVLA) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Apr 17, 2026	Goin Kathleen	officer: Chief Operating Officer	Sell	4,302	$127.24	$547.4K	2,800-61%
Mar 20, 2026	Goin Kathleen	officer: Chief Operating Officer	Sell	4,302	$117.99	$507.6K	2,034-68%
Feb 20, 2026	Goin Kathleen	officer: Chief Operating Officer	Sell	4,302	$79.40	$341.6K	1,276-77%
Feb 18, 2026	Goin Kathleen	Chief Operating Officer	Sell	4,302	$79.40	$341.6K	0
Jan 23, 2026	Goin Kathleen	officer: Chief Operating Officer	Sell	4,302	$97.63	$420.0K	3,749-53%
Dec 19, 2025	Goin Kathleen	Chief Operating Officer	Sell	4,302	$96.47	$415.0K	0Exit
Nov 21, 2025	Goin Kathleen	Chief Operating Officer	Sell	4,302	$86.23	$371.0K	2,802-61%
Sep 1, 2021	Olwill Shane	Chief Development Officer	Sell	38,400	$5.11	$196.4K	33,838-53%